GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Mavik

Company
Baylor Research Institute
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
4 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

4 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Mavik and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02735707

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

    Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
    Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
    View official trial listing →
  • Recruiting NCT NCT02817360

    NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

    Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites
    Type 2 diabetes Other conditions: Heart Diseases
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Recruiting NCT NCT07513883

    The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

    Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT00133692

    INVEST: INternational VErapamil SR Trandolapril STudy

    Not yet reported University of Florida 22000 participants Est. completion 2003-02 1 site
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00233532

    Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)

    Not yet reported Abbott 2000 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00234858

    Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)

    Not yet reported Abbott 280 participants
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00234871

    Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

    Not yet reported Abbott 357 participants
    Other conditions: Hypertension, Diabetes, Proteinuria
    View official trial listing →
  • Completed NCT NCT00235001

    Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

    Not yet reported Abbott 120 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00235014

    A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)

    Not yet reported Abbott 1204 participants
    Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Status unknown NCT NCT00252317

    Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis

    Not yet reported Copenhagen University Hospital, Rigshospitalet 64 participants Est. completion 2008-10 1 site
    Other conditions: Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT00391846

    Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

    Not yet reported AstraZeneca 252 participants Est. completion 2009-01 39 sites
    Heart failure Other conditions: Ventricular Dysfunction, Left
    View official trial listing →
  • Completed NCT NCT00679653

    Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives

    Not yet reported Abbott 171 participants
    Other conditions: Obesity, Hypertension
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00840073

    Trandolapril 4 mg Tablet Under Non-Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 50 participants Est. completion 2004-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00840632

    Trandolapril 4 mg Tablet Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 40 participants Est. completion 2004-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00887510

    Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)

    Not yet reported University of Florida 24 participants Est. completion 2009-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01078584

    Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients

    Abbott 7993 participants Est. completion 2011-09 568 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01127139

    Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension

    Abbott 3828 participants Est. completion 2011-03 134 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01164787

    Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 52 participants Est. completion 2006-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01164800

    Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 52 participants Est. completion 2006-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01437371

    Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?

    Not yet reported University Hospital, Clermont-Ferrand 35 participants Est. completion 2014-06 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01669434

    Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

    Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site
    Other conditions: Hypotension on Induction
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01867047

    ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

    Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site Stand-alone
    Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Enrolling by invitation NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Mavik, Trandolapril

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.